01—Abstract
Summary
Summary of the 10-Q filed May 5, 2026. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group Inc. (UNH) reported its first quarter 2026 results, demonstrating steady revenue growth and robust earnings per share, though facing some membership contractions in key areas.
Total revenues increased by 2% year-over-year to $111.7 billiona, driven by price increases at UnitedHealthcare and growth at Optum Rx, offsetting declines in Medicare Advantage and Medicaid enrollment. Earnings from operations remained strong at $9.0 billion, with diluted earnings per share reaching $6.90, reflecting operational management and favorable reserve development despite increased operating costs. Significant strategic actions were undertaken, including portfolio divestitures and restructuring efforts, which resulted in net gains and impacts across segments like Optum Insight and Optum Health.
While the company experienced a decline in the number of people served by UnitedHealthcare, particularly in Medicare Advantage and Medicaid, due to benefit design, pricing actions, and reduced eligibility, it also initiated forward share repurchase contracts and paid substantial dividends, indicating continued confidence and commitment to shareholder returns. The company is also actively pursuing pending acquisitions expected to close in the latter half of 2026.
02—Key points
Key Highlights
- Total revenues grew 2% to $111.7 billion for the three months ended March 31, 2026, compared to the prior year.
- Diluted earnings per share (EPS) increased to $6.90 from $6.85 in the prior year period.
- UnitedHealthcare served 1.1 million fewer people, primarily due to benefit design and pricing actions, and reduced Medicaid eligibility.
- Optum Health revenues saw a 3% decrease, largely due to fewer patients served under value-based arrangements.
- The company initiated forward share repurchase contracts totaling $500 million as of March 31, 2026.
- Cash flows from operating activities were robust, totaling $8.9 billion for the quarter.
- The company has pending acquisitions totaling approximately $3.0 billion expected to close in the second half of 2026.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2026, UnitedHealth Group Inc kept $0.06.
- Revenue$111.72B100.0%
- Cost of revenue−$12.82B11.5%
- Gross profit$98.90B88.5%
- Operating costs−$89.91B80.5%
- Operating income$8.99B8.0%
- Interest, other & tax−$2.71B2.4%
- Net income$6.28B5.6%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2026filed May 5, 2026Financial Statements
Q1 FY2026 against Q1 FY2025
| Line item | Q1 FY2026Q1 FY2025 | Change |
|---|---|---|
| Revenue | $111.72B$109.58B | +2.0% |
| Cost of Revenue | $12.82B$12.39B | +3.5% |
| Gross Profit | $98.90B$97.19B | +1.8% |
| SG&A Expenses | $15.39B$13.59B | +13.2% |
| Operating Expenses | $102.73B$100.46B | +2.3% |
| Operating Income | $8.99B$9.12B | −1.4% |
| Interest Expense | $955.00M$998.00M | −4.3% |
| Net Income | $6.28B$6.29B | −0.2% |
| EPS (Basic) | $6.92$6.90 | +0.3% |
| EPS (Diluted) | $6.90$6.85 | +0.7% |
| Shares Outstanding (Basic) | 908.00M912.00M | −0.4% |
| Shares Outstanding (Diluted) | 910.00M918.00M | −0.9% |
05—Questions
Frequently Asked Questions
What drove the revenue growth in the first quarter of 2026?
Revenue growth was primarily driven by pricing trends at UnitedHealthcare and growth at Optum Rx. This was partially offset by a decrease in the number of people served through Medicare Advantage, commercial risk-based offerings, and Medicaid, as well as a reduction in patients served under value-based arrangements at Optum Health.
Why did UnitedHealthcare experience a decline in membership?
UnitedHealthcare served 1.1 million fewer people due to a combination of factors including benefit design and pricing actions, reduced Medicaid eligibility, and competitive pressures in the commercial risk market. Specifically, Medicare Advantage enrollment decreased due to funding pressures and risk adjustment model revisions.
How is UnitedHealth Group managing its operating costs and investments?
Operating costs increased by 13% primarily due to investments in people, processes, and technology to enhance consumer and care provider experiences and drive efficiencies. Restructuring and other actions also impacted operating costs. The company is also managing medical costs through affordability initiatives, increased auditing, and clinical policy enforcement, alongside favorable reserve development.
What is the outlook for acquisitions and capital allocation?
UnitedHealth Group has entered into agreements for pending acquisitions totaling approximately $3.0 billion, with most expected to close in the second half of 2026. The company also continues to return capital to shareholders through dividends, with a quarterly cash dividend reflecting an annual rate of $8.84, and through share repurchases, including recently initiated forward contracts.
06—Continue